TAP II (the device for blood sampling)

2021: The announcement of TAP II - the device for blood sampling

At the beginning of February, 2021 the Seventh Sense Biosystems company (7SBio) provided the button device for blood sampling of TAP II at home. It is known that the TAP II device with microneedles of new generation allows to take the bigger volume of blood on the analysis and includes the standardized removable containers for collecting of serum and plasma.

The current standard of blood draw is the venepunktion for which health workers, big needles and a personal meeting with the patient are required. The TAP II device can be used instead of a traditional venepunktion or blood draw from a finger both in professional, and in house conditions. For blood draw the patient needs to place only TAP II on a shoulder and to click. Process of collecting of blood takes only two-three minutes. After completion of collecting the device goes back to laboratory for the analysis.

TAP II (the device for blood sampling)

The CEO of Affinity Biomarker Labs Chris Moriarty noted that simple process of collecting of blood using TAP II not only promotes telemedicine formation in general, but also ensures safety of the population during COVID-19 pandemic.

Our clients - both certain patients, and the medical companies - already estimated simplicity and convenience of using of TAP II and also advantage of such safe and effective collecting of blood at home.

In turn the CEO 7SBio Rick Bente noted that obtaining the certificate of CE and entry of the company into the European market will allow the bigger number of patients to use the new device at home and will simplify access to medical services. The Seventh Sense company already collected more than $80 million for implementation of this mission and continues to advance the patented technology of microneedles used in TAP devices on the new markets.^[1]

Notes